Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview

Emil Scosyrev; James Messing; Katia Noyes; Peter Veazie; Edward Messing

doi:10.1016/j.urolonc.2009.11.005

Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview

Emil Scosyrev
, James Messing
, Katia Noyes
, Peter Veazie
, Edward Messing

Department of Epidemiology and Environmental Health

University at Buffalo

University of Rochester

Research output: Contribution to journal › Review article › peer-review

78 Scopus citations

Abstract

The Surveillance, Epidemiology, and End Results (SEER) program is a commonly used data source in cancer research. This article provides an introduction to the SEER database, describes important data items available from SEER on the most commonly diagnosed urologic malignancies (prostate, bladder, and kidney cancers), and reviews limitations of SEER data for urologic oncology research.

Original language	English
Pages (from-to)	126-132
Number of pages	7
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	30
Issue number	2
DOIs	https://doi.org/10.1016/j.urolonc.2009.11.005
State	Published - Mar 2012

Keywords

Bladder cancer
Kidney cancer
Prostate cancer
SEER

Access to Document

10.1016/j.urolonc.2009.11.005

Cite this

@article{2af21c243e4b4fd687b3b8db943b8b8d,

title = "Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview",

abstract = "The Surveillance, Epidemiology, and End Results (SEER) program is a commonly used data source in cancer research. This article provides an introduction to the SEER database, describes important data items available from SEER on the most commonly diagnosed urologic malignancies (prostate, bladder, and kidney cancers), and reviews limitations of SEER data for urologic oncology research.",

keywords = "Bladder cancer, Kidney cancer, Prostate cancer, SEER",

author = "Emil Scosyrev and James Messing and Katia Noyes and Peter Veazie and Edward Messing",

year = "2012",

month = mar,

doi = "10.1016/j.urolonc.2009.11.005",

language = "English",

volume = "30",

pages = "126--132",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology

T2 - An overview

AU - Scosyrev, Emil

AU - Messing, James

AU - Noyes, Katia

AU - Veazie, Peter

AU - Messing, Edward

PY - 2012/3

Y1 - 2012/3

N2 - The Surveillance, Epidemiology, and End Results (SEER) program is a commonly used data source in cancer research. This article provides an introduction to the SEER database, describes important data items available from SEER on the most commonly diagnosed urologic malignancies (prostate, bladder, and kidney cancers), and reviews limitations of SEER data for urologic oncology research.

AB - The Surveillance, Epidemiology, and End Results (SEER) program is a commonly used data source in cancer research. This article provides an introduction to the SEER database, describes important data items available from SEER on the most commonly diagnosed urologic malignancies (prostate, bladder, and kidney cancers), and reviews limitations of SEER data for urologic oncology research.

KW - Bladder cancer

KW - Kidney cancer

KW - Prostate cancer

KW - SEER

UR - https://www.scopus.com/pages/publications/84857658200

U2 - 10.1016/j.urolonc.2009.11.005

DO - 10.1016/j.urolonc.2009.11.005

M3 - Review article

C2 - 20363162

SN - 1078-1439

VL - 30

SP - 126

EP - 132

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 2

ER -

Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this